These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8316461)

  • 1. [Circulating tumor markers].
    Pichon MF; Pecking A
    Pathol Biol (Paris); 1993 Jan; 41(1):35-6. PubMed ID: 8316461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers and TNM classification].
    Ohkura H
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1981-4. PubMed ID: 9797825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor markers and chemotherapy.
    Francioni S; Pastore M; Castellaro E
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):251-9. PubMed ID: 2092128
    [No Abstract]   [Full Text] [Related]  

  • 4. "Clinical and laboratorial remarks in the measurement of some tumor markers".
    Giuliani F; Neri G; Bertolo M; Binetti L; Rossi C
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):281-4. PubMed ID: 2092134
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison between various tumor marker.
    Pastore M; Sbaffi A; Francioni S; Castellaro E
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):239-50. PubMed ID: 2092126
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating biomarkers from tumour bulk to tumour machinery: promises and pitfalls.
    Gion M; Daidone MG
    Eur J Cancer; 2004 Nov; 40(17):2613-22. PubMed ID: 15541962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cancer by tumor markers in the blood: a view to the future.
    Sell S
    Crit Rev Oncog; 1993; 4(4):419-33. PubMed ID: 8353141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers].
    Sirotteau JC
    Soins; 1990 Feb; (533):33-5. PubMed ID: 2321057
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction to tumor markers from A to Z.
    Plaut D
    MLO Med Lab Obs; 2004 Aug; 36(8):22, 26. PubMed ID: 15366364
    [No Abstract]   [Full Text] [Related]  

  • 10. [Criteria for using tumor markers. 2: Indications and interpretation].
    Fateh-Moghadam VA; Stieber P
    Fortschr Med; 1996 Mar; 114(7):38-40. PubMed ID: 8900968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Good clinical use of serum tumor markers].
    Boussen H; el May M; Jerbi G; Rahal K; Benna F; Mtimet S; Ben Ayed F
    Tunis Med; 1998 Feb; 76(2):1020-6. PubMed ID: 9844536
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelets and VEGF blood levels in cancer patients.
    Gunsilius E; Gastl G
    Br J Cancer; 1999 Sep; 81(1):185-6. PubMed ID: 10487633
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous inappropriate use of serum tumour markers.
    Tran HA
    Intern Med J; 2005 Oct; 35(10):640-1; author reply 641. PubMed ID: 16207270
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular changes in lipids in the early diagnosis of cancer].
    Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):725. PubMed ID: 3438540
    [No Abstract]   [Full Text] [Related]  

  • 15. Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring.
    Wong IH; Lo YM; Johnson PJ
    Ann N Y Acad Sci; 2001 Sep; 945():36-50. PubMed ID: 11708493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour markers - new aspects of an old discussion?
    Fleischhacker M; Beinert T
    Eur J Med Res; 1999 Apr; 4(4):144-8. PubMed ID: 10205289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
    Diamandis EP
    Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tumor markers--how they should be applied].
    Stieber P; Heinemann V; Schalhorn A
    MMW Fortschr Med; 2005 May; 147(20):35, 37-9. PubMed ID: 15957858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of circulating tumor cells as prognostic markers for colon cancer.
    Meropol NJ
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):247-8. PubMed ID: 19521326
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mass spectrometric proteomic analysis of serum samples--a promising method for early diagnosis of cancer].
    Jørgensen PE; Jensen ON; Hørder M
    Ugeskr Laeger; 2002 Dec; 165(1):54-5. PubMed ID: 12529953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.